198 results on '"Binkley, Michael S."'
Search Results
2. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
3. First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema
4. KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
5. Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume
6. SOHO State of the Art Updates and Next Questions |Treatment Approaches for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
7. Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents
8. Inferring gene expression from cell-free DNA fragmentation profiles
9. Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus
10. First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema
11. Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL)
12. Mechanisms and Markers of Clinical Radioresistance
13. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
14. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
15. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
16. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG
17. Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
18. 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy
19. Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient.
20. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
21. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung
22. Cancer Stem Cells and Tumor Radioresistance
23. Supplementary Figures S1-S7 from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
24. Supplementary Table S1 from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
25. Data from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
26. Abstract 5960: Identification and validation of sarcoma cellular ecosystems associated with prognosis and predictive of immunotherapy response
27. Data from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
28. Supplementary Figures 1-9 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
29. Data from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
30. Supplementary Tables S1-S7 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
31. Supplemental Methods from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
32. Supplemental Tables from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
33. Supplemental Figures from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
34. Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma
35. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR)
36. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation
37. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
38. STK11Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
39. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
40. Investigating and modeling positron emission tomography factors associated with large cell transformation from low‐grade lymphomas
41. Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma
42. Characterizing the immune microenvironment for nodular lymphocyte‐predominant Hodgkin lymphoma
43. Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
44. The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
45. Investigating and modeling positron emission tomography factors associated with large cell transformation from low‐grade lymphomas.
46. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)
47. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma
48. Abstract PO-059: Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer
49. Stage I–II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy
50. Additional file 2 of Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.